Silverarc Capital Management »

Tela Bio shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Tela Bio (TELA) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Tela Bio

Tip: Access up to 7 years of quarterly data

All positions including Tela Bio held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tela Bio by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.9M 491k 8.00
2023-06-30 $4.2M 416k 10.13
2023-03-31 $576k 54k 10.64

More positions owned by Silverarc Capital Management

ImmunoGen Long Option Calls Call Option
SPRD S&P Biotech ETF Long Option Calls Call Option (XBI)
Akero Therapeutics Long Option Calls Call Option (AKRO)
Mirati Therapeutics Long Option Calls Call Option
Morphic Holding Equities (MORF)
Merus NV Equities (MRUS)
CymaBay Therapeutics Long Option Calls Call Option
Soleno Therapeutics Equities (SLNO)
Intra-Cellular Therapies Equities (ITCI)
Poseida Therapeutics Equities (PSTX)
Krystal Biotech Equities (KRYS)
Mersana Therapeutics Long Option Calls Call Option (MRSN)
KalVista Pharmaceuticals Long Option Calls Call Option (KALV)
Biogen Idec Equities (BIIB)
Urogen Pharma Equities (URGN)

View all positions for Silverarc Capital Management

Top funds holding Tela Bio

OrbiMed Advisors
First Light Asset Management
AIGH Capital Management
Nantahala Capital Management
Vanguard Group
Pentwater Capital Management
Federated Investors
UBS Group
Kennedy Capital Management
Worth Venture Partners
Perkins Capital Management
Kamunting Street Capital Management
Meros Investment Management
Schonfeld Strategic Advisors
Pnc Financial Services

View all funds holding Tela Bio